Approaches to risk-benefit assessment of seafood consumption: lessons learned from an evidence scan

被引:1
|
作者
Farakos, Sofia M. Santillana [1 ]
Heilman, Jacqueline [1 ]
Abt, Eileen [1 ]
Dennis, Sherri [1 ]
机构
[1] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA
来源
FRONTIERS IN NUTRITION | 2024年 / 11卷
关键词
risk-benefit; risk analysis; RBA; fish; risk management; FISH;
D O I
10.3389/fnut.2024.1290680
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Qualitative and quantitative risk-benefit assessments (RBA) can be used to support public health decisions in food safety. We conducted an evidence scan to understand the state of the science regarding RBA in seafood to help inform seafood dietary advice in the United States. We collected published RBA studies assessing seafood consumption, designed inclusion and exclusion criteria to screen these studies, and conducted systematic data extraction for the relevant studies published since 2019. Our findings indicate the selection of health risks and benefits does not generally follow a systematic approach. Uncertainty and variability in RBAs is often not addressed, and quantitative RBAs making use of a single health metric generally have not been leveraged to directly support published regulatory decisions or dietary guidance. To elevate the role of RBA in supporting regulatory decision-making, risk assessors and risk managers must work together to set expectations and goals. We identified the need for a prioritization phase (e.g., multicriteria decision analysis model) to determine the risks and benefits of greatest public health impact to inform the RBA design. This prioritization would consider not only the degree of public health impact of each risk and benefit, but also the potential for risks and benefits to converge on common health outcomes and their importance to subpopulations. Including a prioritization could improve the utility of the RBAs to better inform risk management decisions and advance public health. Our work serves to guide the United States Food and Drug Administration's approaches to RBA in foods.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] An evidence-based risk-benefit assessment of adalimumab, etanercept, and infliximab in psoriasis
    Strober, Bruce
    Langley, Richard
    Rozzo, Stephen
    Gu, Yihua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB167 - AB167
  • [42] Approaches for Health Effect Characterization in Risk-Benefit Assessment of Foods: A Comparative Case Study
    Thomsen, Sofie Theresa
    Nauta, Maarten
    Jakobsen, Lea Sletting
    Jakobsen, Marianne Uhre
    Mejborn, Heddie
    Outzen, Malene
    Poulsen, Morten
    Ravn-Haren, Gitte
    Andersen, Rikke
    FRONTIERS IN NUTRITION, 2021, 8
  • [43] A risk-benefit assessment of pharmacological therapies for hirsutism
    Carmina, E
    DRUG SAFETY, 2001, 24 (04) : 267 - 276
  • [44] RISK-BENEFIT ASSESSMENT OF ANESTHETIC AGENTS IN THE PUERPERIUM
    KANTO, J
    DRUG SAFETY, 1991, 6 (04) : 285 - 301
  • [46] A risk-benefit assessment of irinotecan in solid tumours
    Siu, LL
    Rowinsky, EK
    DRUG SAFETY, 1998, 18 (06) : 395 - 417
  • [47] Carbapenems in serious infections - A risk-benefit assessment
    Norrby, SR
    DRUG SAFETY, 2000, 22 (03) : 191 - 194
  • [48] A Risk-Benefit Assessment of Pharmacological Therapies for Hirsutism
    Enrico Carmina
    Drug Safety, 2001, 24 : 267 - 276
  • [49] RISK-BENEFIT PROBLEMS IN FOOD SAFETY ASSESSMENT
    FRANCIS, FJ
    JOURNAL OF THE CANADIAN DIETETIC ASSOCIATION-REVUE DE L ASSOCIATION CANADIENNE DES DIETETISTES, 1979, 40 (04): : 274 - 279
  • [50] A TIERED APPROACH FOR RISK-BENEFIT ASSESSMENT OF FOODS
    Fransen, Heidi
    de Jong, Nynke
    Hendriksen, Marieke
    Mengelers, Marcel
    Castenmiller, Jacqueline
    Hoekstra, Jeljer
    van Leeuwen, Rolaf
    Verhagen, Hans
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 661 - 661